Category: HPB & Spleen

Placement of Gastrostomy Tubes at the Time of Pancreaticoduodenectomy: No Impact on Delayed Gastric Emptying

The study investigated the utility of gastrostomy tube placement during pancreaticoduodenectomy in reducing delayed gastric emptying. Results showed no difference in delayed gastric emptying incidence between patients with or without a gastrostomy tube. However, patients with a tube experienced higher postoperative complications, including postoperative ileus and atrial fibrillation. Overall, placement of gastrostomy tubes during pancreaticoduodenectomy […]

Robotic Surgery Shows Promise for Gallbladder Cancer Treatment

Robotic-assisted surgery for gallbladder cancer is found to be as effective as traditional methods in terms of oncological outcomes, with potential benefits in precision and perioperative recovery. A systematic review comparing robotic, open, and laparoscopic techniques highlights the feasibility and safety of robotic surgery, suggesting it as a viable alternative for treatment. Further research is […]

High FDG-Avidity in Pancreatic Cancer: 96.3% Tumors Detected, PET Utility in Initial Staging and Neoadjuvant Therapy Planning

Baseline fdg-pet imaging in treatment naïve pdac patients revealed 96.3% had fdg-avid tumors with median suvmax 6.4. fdg-pet identified suspicious extrapancreatic metastatic lesions in 50% of patients, with pet/mri being superior in detection. Ca19-9 elevation did not affect fdg-pet’s performance, highlighting its utility in initial staging and neoadjuvant therapy planning. Journal Article by Carlson DM, […]

Higher burden and inequality in pancreatic cancer among older adults globally

Between 1990 and 2019, the number of pancreatic cancer deaths in older adults, age-standardized death rate, disability-adjusted life years, and age-standardized DALY rate increased globally. The burden is highest in southern Latin America and has grown fastest in the Caribbean. Males aged 65 to 74 years have a higher burden than females. Proportions of deaths […]

Comparable Long-term Survival Between Laparoscopic and Open Pancreaticoduodenectomy for Pancreatic Tumors

In a randomized clinical trial comparing laparoscopic and open pancreaticoduodenectomy for pancreatic or periampullary tumors, researchers found similar 3-year overall survival rates between the two groups. Quality of life, depression, and other outcomes also showed no significant differences. Laparoscopic pancreaticoduodenectomy, when performed by experienced surgeons, demonstrated comparable long-term outcomes to open surgery. Journal Article by […]

Robotic Pancreaticoduodenectomy Shows Lower Blood Loss and Higher Complication-Free Rates compared to Open Procedure

Researchers compared robotic pancreaticoduodenectomy (RPD) and open pancreaticoduodenectomy (OPD) outcomes in a high-volume center. RPD showed lower blood loss, higher rates of no complications, longer operative time, and fewer harvested lymph nodes in patients with ductal adenocarcinoma compared to OPD. No significant differences were found for major complications, reoperation rate, postoperative pancreatic fistula, or patients […]

Antibiotic Duration Unaffected by Biliary Stents in Pancreatoduodenectomy

Antibiotic duration did not impact infection rates in pancreatoduodenectomy patients with biliary stents. A retrospective cohort study found similar composite infection rates among patients receiving short, medium, or long-duration antibiotics, with no significant differences in other outcomes. Postoperative pancreatic fistula and male sex were associated with the primary outcome. The study suggests an opportunity to […]

Enhanced Survival Benefit with Surgical Resection in BCLC-A/B HCC Beyond Milan Criteria

Patients with BCLC-A/B HCC beyond Milan criteria and tumor burden beyond the up-to-7 criteria but within 3 tumors showed better overall survival with surgical resection compared to transarterial chemoembolization. The seven-eleven criteria can help identify candidates for surgical resection in this patient population, emphasizing the importance of considering SR in resectable patients for optimal treatment […]

Adjuvant Chemoradiation Improves Survival in Resected Biliary Adenocarcinoma

Analyzing a national cancer database, researchers found that adjuvant chemoradiation in resected extrahepatic bile duct or gallbladder adenocarcinoma, following the SWOG S0809 protocol, yielded a median overall survival of 36.9 months. A propensity score-matched cohort revealed a survival benefit for those receiving adjuvant chemoradiation over adjuvant chemotherapy alone, supporting the consideration of multimodal therapy in […]

Robotic distal pancreatectomy has longer operative times but shorter postoperative stays compared to laparoscopic approach

Robotic distal pancreatectomy (rdp) had longer operative times but shorter postoperative stays compared to laparoscopic distal pancreatectomy (ldp). RDP also had fewer pancreatic leaks and required fewer interventions. While RDP was more expensive than LDP, reduced hospital stays and lower reintervention rates partially offset this cost difference. The study found that RDP is a viable […]